Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating activities:
Net loss	$ (7,262)	$ (8,771)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	427	492
Gain (Loss) on Disposition of Property Plant Equipment	0	3
Stock-based compensation	150	1,155
Accretion of debt discount and issuance costs	27	33
Decrease in fair value of derivative liability	0	(37)
Decrease in fair value of warrant liability	(117)	(1,375)
Changes in operating assets and liabilities:
Receivables	(138)	(1,802)
Contract assets	230	(238)
Income taxes receivable / payable	(152)	221
Other receivable	(649)	0
Prepaid expenses and other assets	151	(105)
Accounts payable and other accrued liabilities	658	(242)
Accrued compensation	(322)	(1,305)
Deferred revenue	(1,360)	(3,724)
Net cash used in operating activities	(8,541)	(11,615)
Investing activities:
Purchases of property and equipment	(8)	(216)
Net cash used in investing activities	(8)	(216)
Financing activities:
Principal payments on financing obligations	(376)	(219)
Principal payments on line of credit	(5,000)	(1,840)
Proceeds from line of credit	0	1,840
Principal payment on term loan	0	(1,833)
Payment for line of credit issuance costs	(86)	0
Net proceeds from common stock issuance	0	23,085
Proceeds from issuance of common stock under employee stock plans	0	226
Common stock repurchases to settle employee withholding liability	(19)	(6)
Net cash provided by (used in) financing activities	(5,481)	21,253
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(98)	28
Net increase (decrease) in cash and cash equivalents	(14,128)	9,450
Cash and cash equivalents, beginning of period	20,563	11,878
Cash and cash equivalents, end of period	6,435	21,328
Supplemental disclosures of net cash paid (received) during the period:
Income taxes, net	17	(413)
Interest, net	86	31
Non-cash financing activity:
Reclassification from warrant liability to additional paid-in capital for non-cash exercise	$ 0	$ 560